Prostate Cancer: To Screen or Not to Screen?

Alex Shteynshlyuger; Gerald L. Andriole

doi:10.1016/j.ucl.2009.11.004

Prostate Cancer: To Screen or Not to Screen?

Alex Shteynshlyuger, Gerald L. Andriole

Research output: Contribution to journal › Review article › peer-review

13 Scopus citations

Abstract

The debate about the usefulness of population-based prostate cancer screening has been ongoing for decades. The most current evidence shows limited benefit of population screening, and significant psychological, physical and financial costs. Efforts to improve screening with better markers and more selective treatment may make population-based screening more effective.

Original language	English
Pages (from-to)	1-9
Number of pages	9
Journal	Urologic Clinics of North America
Volume	37
Issue number	1
DOIs	https://doi.org/10.1016/j.ucl.2009.11.004
State	Published - Feb 2010

Keywords

ERSPC trial
PLCO trial
Prostate cancer
Prostate-specific antigen
Screening

Access to Document

10.1016/j.ucl.2009.11.004

Cite this

@article{6d479319d0f447cab65fba4e23b0d16e,

title = "Prostate Cancer: To Screen or Not to Screen?",

abstract = "The debate about the usefulness of population-based prostate cancer screening has been ongoing for decades. The most current evidence shows limited benefit of population screening, and significant psychological, physical and financial costs. Efforts to improve screening with better markers and more selective treatment may make population-based screening more effective.",

keywords = "ERSPC trial, PLCO trial, Prostate cancer, Prostate-specific antigen, Screening",

author = "Alex Shteynshlyuger and Andriole, {Gerald L.}",

year = "2010",

month = feb,

doi = "10.1016/j.ucl.2009.11.004",

language = "English",

volume = "37",

pages = "1--9",

journal = "Urologic Clinics of North America",

issn = "0094-0143",

number = "1",

}

TY - JOUR

T1 - Prostate Cancer

T2 - To Screen or Not to Screen?

AU - Shteynshlyuger, Alex

AU - Andriole, Gerald L.

PY - 2010/2

Y1 - 2010/2

N2 - The debate about the usefulness of population-based prostate cancer screening has been ongoing for decades. The most current evidence shows limited benefit of population screening, and significant psychological, physical and financial costs. Efforts to improve screening with better markers and more selective treatment may make population-based screening more effective.

AB - The debate about the usefulness of population-based prostate cancer screening has been ongoing for decades. The most current evidence shows limited benefit of population screening, and significant psychological, physical and financial costs. Efforts to improve screening with better markers and more selective treatment may make population-based screening more effective.

KW - ERSPC trial

KW - PLCO trial

KW - Prostate cancer

KW - Prostate-specific antigen

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=75449091230&partnerID=8YFLogxK

U2 - 10.1016/j.ucl.2009.11.004

DO - 10.1016/j.ucl.2009.11.004

M3 - Review article

C2 - 20152514

AN - SCOPUS:75449091230

SN - 0094-0143

VL - 37

SP - 1

EP - 9

JO - Urologic Clinics of North America

JF - Urologic Clinics of North America

IS - 1

ER -

Prostate Cancer: To Screen or Not to Screen?

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this